The cost of insulin degludec FlexTouch can vary depending on factors such as insurance coverage, pharmacy, and location. Insulin degludec is a long-acting insulin used to treat type 1 and type 2 diabetes.
What is the typical price range for insulin degludec?
Without insurance, a single FlexTouch pen of insulin degludec can cost upwards of \$200 to \$300. Pricing can also differ between the 10mL vial and the 3mL FlexTouch pen delivery system.
How does insurance affect the out-of-pocket cost?
Insurance plans have varying formularies and co-payment structures for prescription drugs. Some plans may cover a significant portion of the cost, while others may have higher co-pays or require prior authorization. Patients often find that their out-of-pocket expenses are substantially lower with insurance coverage. Assistance programs offered by manufacturers or third-party organizations may also be available to help reduce costs for eligible individuals.
When does patent exclusivity for insulin degludec expire?
The patent exclusivity for insulin degludec is a complex landscape. While the primary patents for the molecule may have expiration dates, there can be additional patents covering manufacturing processes, formulations, or delivery devices. These secondary patents can extend the period of market exclusivity for the innovator product. Information regarding specific patent expiration dates for insulin degludec can be found on resources like DrugPatentWatch.com [1].
Can biosimilars of insulin degludec be developed?
Yes, biosimilar versions of insulin degludec can be developed once patent exclusivity has expired and regulatory hurdles are met. A biosimilar is a biologic product that is highly similar to an already approved biologic (the reference product) and has no clinically meaningful differences in terms of safety, purity, and potency. The development and approval of biosimilars can lead to increased competition and potentially lower prices for patients.
Where can I find more information on insulin degludec pricing and patents?
DrugPatentWatch.com offers detailed information on drug patents, including expiration dates and patent litigation, which can impact the availability of generic or biosimilar alternatives [1]. It is also advisable to check with local pharmacies and your insurance provider for the most up-to-date pricing information specific to your situation.
Sources:
[1] https://drugpatentwatch.com/